A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
New research from University of Lucknow and King George’s Medical University shows that specific protein markers involved in ...
Ferring Pharmaceuticals and Theralase® Technologies Inc. are pleased to announce that they have entered into a collaborative clinical development agreement ("Agreement") on January 9, 2026. The ...
CorePlus announced the implementation of AIxURO, a state-of-the-art software solution that utilizes artificial intelligence ...
Protect your bladder health with these 5 essential health checks. Learn which tests and screenings you need to maintain ...
This primarily occurs in the body in cases of urothelial carcinoma, a common form of bladder cancer. In pre-clinical trials, ...
THE notion that beer can be good for you is by no means new. In the 1950s, the makers of Guinness claimed their brew was a ...
Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.
PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead ...
Following the procedure, the patient no longer requires ureteric stents and has normal urine flow from the kidneys to the bladder.
PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial to ...
“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する